# A Single Dose Pharmaco-Diagnostic for Peripheral Nerve Continuity After Trauma

> **NCT04026568** · PHASE2,PHASE3 · TERMINATED · sponsor: **Milton S. Hershey Medical Center** · enrollment: 1 (actual)

## Conditions studied

- Nerve Injury

## Interventions

- **DRUG:** 4-Aminopyridine
- **DRUG:** Placebo oral tablet

## Key facts

- **NCT ID:** NCT04026568
- **Lead sponsor:** Milton S. Hershey Medical Center
- **Sponsor class:** OTHER
- **Phase:** PHASE2,PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2021-08-17
- **Primary completion:** 2022-07-18
- **Final completion:** 2022-07-18
- **Target enrollment:** 1 (ACTUAL)
- **Why stopped:** Study investigator left Institution
- **Last updated:** 2022-10-18


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04026568

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04026568, "A Single Dose Pharmaco-Diagnostic for Peripheral Nerve Continuity After Trauma". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT04026568. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*